|
TRAF3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30760005443176E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49290000001279E-06 |
| Normal-vs-Stage2 |
1.964910E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.503600E-02 |
| Stage1-vs-Stage2 |
8.133400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.586600E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.466400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.80650000017424E-07 |
| Normal-vs-AfricanAmerican |
1.769580E-01 |
| Normal-vs-Asian |
2.988200E-02 |
| Caucasian-vs-AfricanAmerican |
9.419800E-01 |
| Caucasian-vs-Asian |
3.383000E-01 |
| AfricanAmerican-vs-Asian |
3.443400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.172900E-04 |
| Normal-vs-Female |
1.83605999999337E-05 |
| Male-vs-Female |
3.359600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.620400E-03 |
| Normal-vs-Extreme_Weight |
4.992700E-04 |
| Normal-vs-Obese |
1.778340E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
1.957370E-01 |
| Normal_Weight-vs-Obese |
3.412400E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
3.689600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
3.238600E-01 |
| Normal-vs-Grade 3 |
1.993230E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.494600E-01 |
| Grade 2-vs-Grade 4 |
3.238600E-01 |
| Grade 3-vs-Grade 4 |
1.993230E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1865999994849E-07 |
| Normal-vs-N1 |
3.570000E-02 |
| N0-vs-N1 |
9.633700E-02 |
|
|
